awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38624864-E7637772-C3C6-4BD2-B908-793717DA046A
Q38624864-E7637772-C3C6-4BD2-B908-793717DA046A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38624864-E7637772-C3C6-4BD2-B908-793717DA046A
Optimal treatment of poor-risk renal cell carcinoma patients with mTOR inhibitors and anti-VEGFR agents.
P2860
Q38624864-E7637772-C3C6-4BD2-B908-793717DA046A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38624864-E7637772-C3C6-4BD2-B908-793717DA046A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff98df58ef3ddbdbd4e2d184074f066f3de2ff26
P2860
Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.